Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
PEER-Heart
1 other identifier
interventional
200
1 country
1
Brief Summary
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2024
CompletedFirst Posted
Study publicly available on registry
June 17, 2024
CompletedStudy Start
First participant enrolled
August 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2029
March 21, 2025
March 1, 2025
4.9 years
June 11, 2024
March 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Linkage to cardiology care
Proportion of participants who are engaged in cardiac care at 2 months after screening.
2 months
Secondary Outcomes (2)
Linkage to diagnostic echocardiogram
2 months
Goal Directed Medical Therapy (GDMT) prescribed
6 months
Study Arms (2)
Peer-supported Treatment as Usual
ACTIVE COMPARATORParticipants will receive a peer-supported referral to a local primary care provider who will create a plan to treat the participants heart failure.
Peer-Supported Telehealth Cardiology
EXPERIMENTALParticipants will receive a virtual consultation with a cardiovascular specialist, referral for a locally performed echocardiogram (ECG), and transitional care management facilitated by a remote nurse care manager and the peer to treat the participants heart failure.
Interventions
Peer-facilitated referral to a local primary care provider to follow-up their screening results.
Peer-facilitated virtual consultation with cardiovascular specialist, for follow-up of their screening results. Activities may include: referral for a locally performed testing including echocardiogram and additional blood work, and transitional care management facilitated by a remote nurse care manager and the peer Referral for a locally performed testing including echocardiogram Transitional care management facilitated by a remote nurse care manager and the peer
Eligibility Criteria
You may qualify if:
- Patient-defined regular use of methamphetamine in the last year
- Any methamphetamine use in the past 30 days
- Age 18 years or older
- No client-reported diagnosis of heart failure
- Able to communicate in English
- Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms
You may not qualify if:
- Self-reported engagement in medical care for heart failure in past 6 months.
- Actively taking medications for heart failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oregon Health and Science Universitylead
- University of Washingtoncollaborator
- Bay Area First Stepcollaborator
Study Sites (1)
Oregon Health & Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Chan, MD, MPH
Oregon Health and Science University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 11, 2024
First Posted
June 17, 2024
Study Start
August 19, 2024
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
June 30, 2029
Last Updated
March 21, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Following data lock.
De-identified data may be shared following data lock with the data coordinating center at University of Washington.